Serum IL-10 as a marker of severe dengue infection

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Malavige, Gathsaurie Neelika ^a,c   Gomes, Laksiri ^a   Alles, Lukmall ^a   Chang, Thashi ^b   Salimi, Maryam ^c   Fernando, Sachie ^b   Nanayakkara, Kushan D L ^b   Jayaratne, S D ^a   Ogg, Graham S ^c  

^a UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^b UNIVERSITY OF COLOMBO   (Sri Lanka)

^c NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 10; MACROPHAGE MIGRATION INHIBITION FACTOR;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DENGUE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PLEURA EFFUSION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; VOMITING;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; DENGUE; FEVER; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-10; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS;

EID: 84880383129     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-341     Document Type: Article

References (18)

1. Callaway E. Dengue fever climbs the social ladder. Nature 2007, 448:734-735.
2. Dengue in Sri Lanka Dengue in Sri Lanka., http://www.epid.gov.lk/web/index.php?option=com_content&view=article&id=171%3Adengue-update&catid=51%3Amessage-for-public&Itemid=487&lang=en
3. WHO Dengue guildelines for diagnosis, prevention and control, New edition 2009, Geneva: World Health Organisation, WHO.
4. Santiago A, Fernandez-Sein A. Dengue in children: critical points in management. P R Health Sci J 2001, 20(4):343-346.
5. Singhi S, Kissoon N, Bansal A. Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. J Pediatr 2007, 83(2 Suppl):S22-S35.
6. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 2006, 74(1):142-147.
7. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Rothman AL, Ennis FA. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 1999, 59(3):329-334. 10.1002/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.0.CO;2-G, 10502265.
8. Pinto LM, Oliveira SA, Braga EL, Nogueira RM, Kubelka CF. Increased pro-inflammatory cytokines (TNF-alpha and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever. Memorias do Instituto Oswaldo Cruz 1999, 94(3):387-394. 10.1590/S0074-02761999000300019, 10677762.
9. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008, 8:86. 10.1186/1471-2334-8-86, 2474613, 18578883.
10. Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, Tannenbaum SR. Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis 2012, 6(11):e1887. 10.1371/journal.pntd.0001887, 3510095, 23209847.
11. Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic Fever. Pediatr Infect Dis J 2012, 31(12):e232-e238. 10.1097/INF.0b013e31826fd456, 22926216.
12. Rathakrishnan A, Wang SM, Hu Y, Khan AM, Ponnampalavanar S, Lum LC, Manikam R, Sekaran SD. Cytokine expression profile of dengue patients at different phases of illness. PLoS One 2012, 7(12):e52215. 10.1371/journal.pone.0052215, 3527385, 23284941.
13. Malavige GN, Huang LC, Salimi M, Gomes L, Jayaratne SD, Ogg GS. Cellular and cytokine correlates of severe dengue infection. PLoS One 2012, 7(11):e50387. 10.1371/journal.pone.0050387, 3510251, 23209731.
14. Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, Cuzzubbo A, Devine PL. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. AmJTrop Med Hyg 1999, 60(4):693-698.
15. Sang CT, Cuzzubbo AJ, Devine PL. Evaluation of a commercial capture enzyme-linked immunosorbent assay for detection of immunoglobulin M and G antibodies produced during dengue infection. Clin Diagn Lab Immunol 1998, 5(1):7-10. 121382, 9455871.
16. Yu X, Zhang X, Zhao B, Wang J, Zhu Z, Teng Z, Shao J, Shen J, Gao Y, Yuan Z, et al. Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS One 2011, 6(12):e28680. 10.1371/journal.pone.0028680, 3235144, 22174866.
17. Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, Forshey BM, Halsey ES, Comach G, Sierra G, Blair PJ, et al. A three-component biomarker panel for prediction of dengue hemorrhagic fever. Am J Trop Med Hyg 2012, 86(2):341-348. 10.4269/ajtmh.2012.11-0469, 3269290, 22302872.
18. Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, Cabrera MV, Rodriguez R, Rosario D, Martinez E, Denny T, et al. IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 2004, 73(2):230-234. 10.1002/jmv.20080, 15122797.